ACCELERON PHARMA INC (XLRN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-11-24
3:48 pm
Sale
2021-11-2213DACCELERON PHARMA INC
XLRN
Avoro Capital Advisors LLC0
0.000%
-4,476,100decrease
(Position Closed)
Filing
History
2021-11-10
12:24 pm
Sale
2021-11-0913GACCELERON PHARMA INC
XLRN
FMR LLC493,493
0.807%
-4,184,920decrease
(-89.45%)
Filing
History
2021-10-05
12:30 pm
Purchase
2021-09-3013DACCELERON PHARMA INC
XLRN
Avoro Capital Advisors LLC4,476,100
7.300%
4,476,100increase
(New Position)
Filing
History